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Abstract
Background: There is increasing evidence that the incidence of  postoperative residual paresis after using neuromuscular blockers ranges 
from 24 to 50% in post anaesthesia care unit (PACU) and is associated with postoperative complications such as critical respiratory events 
as evidenced by hypoxia, hypoventilation and upper airway obstruction. Quantitative neuromuscular monitoring (such as the assessment of  
Train of  four (TOF) ratio) and reversal of  neuromuscular blockers has been shown to reduce postoperative residual paresis. There are very 
few outcome studies on effect of  residual paresis in PACU. There is a paucity of  published randomized controlled trials investigating whether 
using a TOF ratio ≥0.9 before endotracheal extubation compared to clinical assessment of  return of  neuromuscular function reduces the 
incidence of  critical respiratory events in PACU.
Objective: To determine whether using TOF ratio ≥ 0.9 compared to clinical assessment of  return of  neuromuscular function before endo-
tracheal extubation reduces the incidence of  critical respiratory events in PACU
Methods: Onehundred sixty eight adult patients in ASA physical status I and II requiring general anaesthesia for elective surgery with cisa-
tracurium as the muscle relaxant were randomized into 2 groups of  84 each. Group 1 were patients who required a TOF ratio of  ≥0.9 before 
extubation. Group 2 patients were extubated based on clinical assessment of  return of  adequate neuromuscular function by the anaesthetist 
as is the standard of  practice at the Aga Khan University hospital Nairobi. General anaesthesia was standardized in both groups. Both the 
investigators and patients were blinded during the study.
Once the patient was transferred to PACU, oxygen saturation (SP02), respiratory rate and any signs of  upper airway obstruction as demon-
strated by stridor, laryngospasms or requirement of  any airway manipulation was recorded for the first 30 minutes. Duration of  anaesthesia 
and surgery was also recorded. Patient demographics were recorded and analyzed.
Results: There was no statistical difference between the 2 groups in terms of  patient demographics, duration of  surgery and anaesthesia and 
duration since last muscle relaxant was given. In terms of  hypoxia on arrival in PACU, the incidence of  mild hypoxia (SPO2 90-93%) was 11% 
in clinical assessment groupversus 5% in TOF group P-value 0.149 while severe hypoxia (SPO2 <90%) was 19% versus 10% P-value 0.078. 
During the first 30 minutes in PACU, the incidence of  mild hypoxia (SPO2 90-93%) was statistically significant between the 2 groups (12% 
in clinical assessment group versus 1% in TOF group, P-value 0.005) while severe hypoxia (SPO2 <90%) was 7% versus 5%, P-value 0.373. 
The incidence of  upper airway obstruction was statistically significant between the two groups (45% in clinical assessment group versus 14% 
in TOF group P-value<0.0001 for patients requiring airway maneuver, 21% versus 2% P-value <0.0001 for those who required tactile stimu-
lation and 31% versus 12% were snoring, P-value 0.003. Logistic regression analysis revealed TOF group was less likely associated with mild 
hypoxia (OR 0.09 95% CI 0.01-0.71 P-value 0.023), tactile stimulation (OR 0.09 95% CI 0.02-0.40 P-value 0.002), airway maneuver (OR 0.20 
95% CI 0.10-0.43 P-value <0.001) and snoring (OR 0.30 95% CI 0.13-0.68 P-value 0.04).
Conclusion: Among this population, there is a lower incidence of  critical respiratory events in PACU with the use of  neuromuscular moni-
toring using TOF ratio ≥0.9 to assess neuromuscular function before endotracheal extubation compared with the use of  clinical assessment 
methods.
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Introduction
Muscle relaxation is required for tracheal intubation and 
to facilitate surgical procedures as part of  balanced an-
aesthesia1. If  it is not adequately reversed after surgery, 
residual paresis leads to muscle weakness, respiratory 
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problems, prolonged stay in post anaesthesia care unit ( 
PACU), and delayed recovery2,3.
On recovery from muscle relaxation, the anaesthesiolo-
gist can assess for return of  muscle power using a clini-
cal criteria that includes the ability to lift the head for 5 
seconds or hold a tongue depressor between the teeth. 
These clinical methods are unreliable and may be affected 
by other factors such as sedation or inability of  the pa-
tient to follow instructions4.
When neuromuscular monitoring is used, qualitative 
methods such as tactile or visual assessment of  the de-
gree of  neuromuscular block are inaccurate5. It is there-
fore clear that in addition to monitoring neuromuscular 
block clinically, quantitative methods such as accelero-
myography, mechanomyography or electromyography 
should also be used4.
Residual muscle paresis is defined by a Train of  four 
(TOF) ratio <0.9 with correlating signs and symptoms 
of  muscle weakness6. Postoperative residual paresis can 
be reduced by monitoring neuromuscular blockade in 
the operating room7. A recent study by Eikermann et 
al showed that mild degrees of  residual muscle paresis 
(TOF ratios of  0.7-0.9) can be associated with profound 
impairment of  respiratory and pharyngeal muscle func-
tion6. This may be associated with respiratory events and 
aspiration in PACU. Therefore, complete recovery of  
muscle function should be present before tracheal extu-
bation to avoid these risks.
PACU critical respiratory event has been defined as 
“any unanticipated hypoxemia (haemoglobin oxygen 
saturation < 90%), hypoventilation (respiratory rate <8 
breaths/minute) or upper airway obstruction (stridor or 
laryngospasm) requiring an active or specific intervention 
(ventilation, airway manipulation, insertion of  an oral/
nasal airway, opioid or muscle relaxant reversal or tracheal 
intubation)”8.
Most studies done globally show that postoperative pul-
monary complications come second to postoperative 
nausea and vomiting in terms of  PACU complications9. 
A meta-analysis by Naguib et al demonstrated that the 
use of  a neuromuscular monitor is not associated with 
a decreased incidence of  postoperative residual paresis10. 
However, this meta-analysis relied heavily on cohort stud-
ies and the authors recommended more randomised con-
trol trials on this subject matter.
Neuromuscular monitoring is done irregularly in spite 
of  availability of  neuromuscular monitors in developed 
and developing countries. The reason for this practice is 
not due to financial capability but may be due to lack of  
knowledge among medical staff  on availability of  oth-
er methods of  monitoring neuromuscular blockade. The 
other reason is often the lack of  confirmed data and pub-
lished research on the topic.
This study was designed determine whether using TOF 
ratio ≥0.9 compared to clinical assessment of  return of  
neuromuscular function before endotracheal extuba-
tion reduces the incidence of  critical respiratory events 
in PACU. Our study question was: does neuromuscular 
monitoring using TOF ratio≥0.9 compared to clinical 
assessment of  return of  neuromuscular function before 
endotracheal extubation reduce critical respiratory events 
in PACU?
 
We hypothesized that there would be a decrease in the 
incidence of  critical respiratory events in PACU when 
neuromuscular monitoring using TOF ratio ≥0.9 is used 
before endotracheal extubation compared to clinical as-
sessment of  return of  neuromuscular function. Our pri-
mary objective was to determine whether using TOF ratio 
≥0.9 compared to clinical assessment of  return of  neuro-
muscular function before endotracheal extubation reduc-
es the incidence of  critical respiratory events in PACU. 
Our secondary objectives were determine incidence and 
severity of  hypoxia in PACU and to determine incidence 
of  upper airway obstruction in PACU.
 
Methods
This study was performed following approval by the 
health research ethics committee of  the Aga Khan Uni-
versity, East Africa. It was a double blinded prospective 
randomized control trial. Since Nairobi is a cosmopolitan 
city, the patients served by the hospital cut across most 
racial groups present within the country. Patients were re-
cruited from the pre-anaesthesia clinics, which run on a 
daily basis, wards and day-care unit. The study population 
included all adults aged between 18 and 65 years under-
going elective surgery at Aga Khan University hospital 
Nairobi. The sample population included 168 ASA I and 
II adult patients undergoing elective surgery under gen-
eral anaesthesia.
All adults, aged 18-65 year American society of  anaesthe-
siology (ASA) physical status I and II undergoing elective 
surgery under general anaesthesia were included in this 
study. Reasons for exclusion were:
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1. ASA status III and above
2. Pregnant women
3. Patients with neuromuscular diseases
4. Patients on medications that interfere with neuromus-
cular junction function. For example, magnesium sul-
phate and aminoglycosides
5. Patients with renal, hepatic or respiratory diseases
6. Patient refusal to take part in the study
7. Patients with BMI >30
8. Patients allergic to cisatracurium
9. Patients undergoing brain surgery
10. Children and the elderly
A sample size of  168 patients (84 per group) was suffi-
cient to demonstrate 11% difference in the incidence of  
hypoxia and upper airway obstruction between the TOF 
ratio group and clinical assessment group at 95% confi-
dence level and a power of  80%. We therefore hypoth-
esized there would be a difference of  at least 11% be-
tween the TOF ratio group and clinical assessment group. 
Patients were informed of  the nature of  the study and 
recruited if  eligibility criteria were met. Eligible patients 
received written and oral explanations on the purpose 
and nature of  the study. The patients who gave written 
informed consent were enrolled into the study and their 
files tagged with a special colour sticker for ease of  iden-
tification. Participant flow diagram is shown in figure 1.
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Figure 1: Flow diagram of patient distribution 
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Randomized 168 
Clinical evaluation group 84 TOF ratio group 84 
Lost to follow up 0 Lost to follow up 0 
Analyzed 168 
Excluded 10 
5 declined 
to consent 
3 asthmatic  
2 were ASA 
III  
809
Simple randomization was generated by the statistician 
using a computer program. Each of  the random numbers 
was sequentially assigned to either:
Group 1: TOF ratio
Group 2: Clinical assessment
These numbers were sealed in envelopes and delivered 
to the anaesthetist administering general anaesthesia. All 
physicians administering general anaesthesia were sensi-
tized and trained on how to use the acceleromyographic 
nerve stimulator machine (TOF- WatchR SX, Organon). 
The principal investigator, research assistants and patients 
were not aware of  the groups assigned.
 
General anaesthesia was standardized in the patients en-
rolled in the study. Upon entering theatre, the anaesthe-
tist administering general anaesthesia was given a sealed 
envelope containing the group the patient had been ran-
domised to. In the TOF ratio group, 2 surface electrodes 
were placed over the ulnar nerve at the wrist after cleans-
ing and rubbing the skin with an alcohol solution. The 
acceleration transducer was then attached on the volar as-
pect of  the distal phalanx of  the thumb. Current selected 
was 50mA for all the patients in this group (TOF watchR 
SX, Organon). This was done after the patient was under 
anaesthesia.
Intraoperative monitoring included non-invasive blood 
pressure, electrocardiography, pulse oximetry, capnogra-
phy and core temperature monitoring via a nasopharyn-
geal temperature probe. Intravenous induction was done 
with 2mcg/kg of  fentanyl, 2-2.5mg/kg propofol, and 
0.2mg/kg of  cisatracurium. Orotracheal intubation was 
done after two to three minutes of  bag ventilation and 
thereafter ventilation was controlled with a tidal volume 
of  6 to 8mls/kg, respiratory rate was varied to maintain 
end-tidal carbon dioxide between 30-35mmHg.
Anaesthesia was maintained by isoflurane 1-2% in oxygen 
and air to maintain oxygen saturations above 98%. End 
tidal isoflurane was adjusted to keep blood pressure with-
in 20% of  baseline values. Any drop in blood pressure 
below this recommended level was corrected with 3-6mg 
boluses of  ephedrine. Muscle relaxation was maintained 
with 0.05mg/kg of  cisatracurium boluses every 30 to 45 
minutes as is the routine practice in our hospital. Last 
top-up of  muscle relaxant was at least 30 minutes before 
end of  anaesthesia.
Patients received standard analgesia of  morphine 0.1mg/
kg, paracetamol 15mg/kg and with a non-steroidal an-
ti-inflammatory agent unless contra-indicated. Ondanse-
tron 4mg with or without dexamethasone 8mg was given 
to all patients as prophylaxis against postoperative nausea 
and vomiting. Patients were kept warm by warm blankets, 
infusion of  warm fluids and ambient theatre temperature 
of  240C. Core temperature was maintained above 350C.
During reversal, isoflurane and air were switched off  and 
patient was put on 100% oxygen. Oropharyngeal suction-
ing was done. Neostigmine 50micrograms/kilogram to a 
maximum of  5mg and atropine 20microgram/kilogram 
were given.
In the TOF ratio group, the patient required a TOF ra-
tio ≥0.9 before beingextubated and transferred to post 
anaesthesia care unit. In the clinical assessment group, 
the patient required head lift for at least 5 seconds, tid-
al volume 4-6ml/kg with a regular respiratory rate of  at 
least 12 breaths or coughing or pulling on the orotrache-
al tube before being extubated. Extubation was followed 
by gentle oral suctioning after which the patient received 
100% supplemental oxygen by face mask with pulse ox-
imetry monitoring until just before being transferred to 
post anaesthesia care unit. This is the routine practice in 
our hospital.
The patient was then transferred to PACU when the 
anaesthetist was comfortable with their clinical status. 
During transport, no oxygen was given. This is routine 
practice in our hospital.
Once the patient got to PACU, a pulse oximeter was con-
nected by the investigator who was blinded to the study 
and baseline SPO2 recorded. After that, all the patients 
received oxygen 6L/minute via the Hudson mask as is 
the practice in the hospital. Sustained SPO2 ‹ 90% for 
at least 5 seconds with a good pulse oximetry waveform 
was considered severe hypoxemia while SPO2 90-93% 
mild hypoxemia. SPO2 was recorded continuously for 30 
minutes. Any features of  airway obstruction such as stri-
dor, laryngospasms, airway manipulation by chin lift, jaw 
thrust or requirement of  an oral airway or tactile stimula-
tion or re-intubation, were recorded.
Data was collected by the principal investigator or re-
search assistant in the PACU using the data collection 
form. The collected data was counterchecked for com-
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plete entry by the principal investigator and then entered 
into an MS-Excel data base. Data was analyzed using STA-
TA version 11. Data was presented in tables. In terms of  
patients’ demographic data, median values were used to 
represent age and body mass index and Wilcoxon signed 
rank sum test was used to compare the two groups. Sex, 
ASA status, smoking and operative procedures were pre-
sented as proportions and Pearson chi square test was 
used to compare the two groups.
Perioperative variables such as duration of  surgery and 
anaesthesia, duration since last muscle relaxant was given 
were presented as means with standard deviations and two 
sample t-test used to compare the two groups. Outcome 
variables such as hypoxia, respiratory rate and indicators 
of  upper airway obstruction such as tactile stimulation, 
airway maneuvers, snoring and re-intubation were pre-
sented as proportions and Pearson chi square test used 
to compare the two groups. Logistic regression analysis 
using both univariate and multivariate analysis where ap-
plicable was used to test for association between hypoxia 
and upper airway obstruction and study arm, operative 
procedure, duration of  anaesthesia, duration since last 
muscle relaxant and BMI. These were presented as odds 
ratios with 95% confidence intervals. P-value of  less than 
0.05 was considered as statistically significant.
 
Results
One hundred sixty eight patients fulfilled the inclusion cri-
teria and wererandomized into the study. No patient was 
excluded because of  violation of  study protocol. There 
was no statistical difference between the two groups in 
terms of  patient demographic data. However, among op-
erative procedures, there were more urologic procedures 
in the clinical assessment group (21% versus 8%, P-value 
0.027) than TOF group as shown in table 1.)
Table 1 shows patient characteristics 
 
  Clinical assessment 
group 
TOF group P-values 
Number 
Sex, M:F 
Age in yrs 
BMI 
ASA status 
  
 I 
II 
Smoking, No/Yes 
Operative procedures 
ENT 
General 
Gynecologic 
Maxillofacial 
Ophthalmologic 
Orthopedics 
Urologic 
Plastic 
N=84 
38(45%),46(55%) 
37.5(29-47) 
25.5(22.4-27.3) 
  
57(68%) 
27(32%) 
80(95%), 4(5%) 
  
2(2%) 
23(27%) 
21(25%) 
1(1%) 
1(1%) 
19(23%) 
17(21%) 
0(0%) 
  
N=84 
36(43%),48(57%) 
37(30-44) 
24.65(22.45-27.2) 
  
61(73%) 
23(27%) 
80(95%), 4(5%) 
  
3(4%) 
23(27%) 
30(36%) 
5(6%) 
0(0%) 
15(18%) 
7(8%) 
1(1%) 
  
0.756 
0.8192 
0.9380 
  
0.500 
0.500 
1.000 
  
0.650 
1.000 
0.131 
0.096 
0.316 
0.442 
0.027 
0.316 
Median and 25th-75th percentiles are given for age and BMI. Otherwise, numbers of patients (and % of patients) are 
given. 
P-values for patients’ data with median were calculated using Wilcoxon rank sum test while those with proportions 
were calculated using Pearson Chi-square test. 
BMI-Body mass index, ASA- American Society of Anaesthesiology, ENT-Ear, Nose and Throat 
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Intraoperative variables such as duration of  anaesthesia 
(130+ 71 mins versus 130+70 mins, P value 0.6994), du-
ration of  surgery (114±66 mins versus119±67 mins, P 
value 0.6018)   and duration since last muscle relaxant 
(53±16 mins versus 53±15, P value 0.9806)  were not 
statistically significant between the two groups as shown 
in table 2. 
Table 2 shows Perioperative variables 
       
  Clinical 
assessment 
group 
TOF 
group 
95%Confidence 
intervals 
P-
values 
Anaesthetic duration (mins) 
  
Surgical duration (mins) 
130±71 134±70 -25.7 to 17.3 0.6994 
114±66 119±67 -25.8 to 15.0 0.6018 
Duration since last muscle relaxant (mins) 53±16 53±15 -4.9 to 4.8 0.9806 
 
 
 
 
Patients with SPO2 values >94% in post anaesthesia care 
unit were more in the TOF group than clinical assess-
ment group (85% versus 70% on arrival, P-value 0.016 
and 94% versus 81% within 30 minutes, P-value 0.010) 
as shown in table 3 and 4. Hypoxia was not statistically 
significant between the two groups on arrival in PACU. 
However, while in PACU, mild hypoxia (90-93%) was 
more in the clinical assessment group than in the TOF 
group (12% versus 1%, P-value 0.005) as shown in table 
4.
Table 3 shows SPO2 values on arrival in post anaesthesia care unit 
  
  Clinical assessment 
group 
TOF group P-values 
No. with SPO2 >94% 
  
No. with SPO2 90-93% 
  
No. with SPO2 <90% 
59(70%) 
  
9(11%) 
  
16(19%) 
72(85%) 
  
4(5%) 
  
8(10%) 
0.016 
  
0.149 
  
0.078 
 
 
 
Table 4 shows SPO2 values for first 30 minutes in the post anaesthesia care unit 
  
  Clinical assessment 
group 
TOF group  P-values  
No. with SPO2 >94% 
  
No. with SPO2 90-93% 
  
No. with SPO2 <90% 
68(81%) 
  
10(12%) 
  
6(7%) 
79(94%)       0.010 
  
1(1%)         0.005 
  
4(5%)           0.373 
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In terms of  upper airway obstruction in the PACU, 45% 
of  patients in the clinical assessment group compared 
to 14% in the TOF group required an intervention such 
as jaw thrust/chin lift, oropharyngeal airway (P-value 
<0.0001). 21% versus 2% required tactile stimulation to 
maintain their airway (P-value <0.0001). 31% versus 12% 
were snoring in PACU (P-value 0.003). This was statis-
tically significant as shown in table 5. There was no dif-
ference in respiratory rate between the two groups. No 
patient required re-intubation in PACU.
Table 5 shows airway variables in the post anaesthesia care unit 
  
  Clinical 
assessment 
group 
TOF group P-value 
No. requiring airway maneuver, Yes/No 
  
Tactile stimulation, Yes/No 
  
Snoring, Yes/No 
  
Respiratory rate 
  
Re-intubation, Yes/No 
38(45%),46(55%) 
  
18(21%), 66(79%) 
  
26(31%),58(69%) 
  
16±2 
  
0(0%), 84(100%) 
12(14%),72(86%) 
  
2(2%), 82(98%) 
  
10(12%),74(88%) 
  
17±3 
  
0(0%), 84(100%) 
<0.0001 
  
<0.0001 
  
0.003 
  
0.0890 
  
0.36 
 
Discussion
The time between extubation and recovery of  TOF ra-
tios ≥ 0.9 represents a particular vulnerable period for 
adverse respiratory events11. Several other factors may be 
associated with residual paresis in PACU. These include 
duration of  anaesthesia and surgery, type of  muscle re-
laxant used and use of  reversal agent for NMBA at end 
of  anaesthesia. In this study, anaesthetic technique was 
standardized and neostigmine was given as reversal agent. 
Cisatracurium was used in both groups and duration of  
anaesthesia and surgery was not statistically significant.
On patient demographics, there was no statistically sig-
nificant difference between the two groups. However, in 
terms of  operative procedures, there were many urologic 
cases in the clinical assessment group compared to the 
TOF group (21% versus 8% P-value 0.027). However, 
this study was not powered to look at the effect of  in-
dividual surgical procedure on critical respiratory events. 
Other operative procedures were similar between the two 
groups.
There were many patients with SPO2 > 94% in the TOF 
group compared to clinical assessment group on arrival in 
PACU and during the first 30 minutes (85% versus 70%, 
P-value 0.016 and 94% versus 81%, P-value 0.010). On 
the other hand, the incidence of  mild hypoxia (SPO2 90-
93%) in PACU was 12% in the clinical assessment group 
compared to 1% in the TOF group (P-value 0.005). Lo-
gistic regression analysis, table 6, showed a patient was 
less likely to develop mild hypoxia if  in the TOF group 
compared to clinical assessment group (unadjusted OR 
0.09 95% CI 0.01-0.71 P-value 0.023), adjusted OR 0.11 
95% CI 0.14-0.93 P-value0.043). The incidence of  severe 
hypoxia (SPO2<90%) was 7% versus 5% P-value 0.373.
This could be due to active interventions that are under-
taken by PACU staff  hence minimizing cases of  severe 
hypoxia. However, this is clinically significant given that 
Murphy et al demonstrated 0% incidence of  severe hy-
poxia in PACU when using acceleromyography intraop-
eratively for monitoring neuromuscular function11. This 
could be due to higher patient to nurse ratio in our PACU 
whereby one nurse takes care of  two patients or even at 
times three patients. This is in comparison to recommen-
dations of  one nurse to one patient. In the Murphy study, 
one patient was recovered by one nurse in PACU.
Table 5 shows airway variables in the post anaesthesia care unit 
  
  Clinical 
assessment 
group 
TOF group P-value 
No. requiring airway maneuver, Yes/No 
  
Tactile stimulation, Yes/No 
  
Snoring, Yes/No 
  
Respiratory rate 
  
Re-intubation, Yes/No 
38(45%),46(55%) 
  
18(21%), 66(79%) 
  
26(31%),58(69%) 
  
16±2 
  
0(0%), 84(100%) 
12(14%),72(86%) 
  
2(2%), 82(98%) 
  
10(12%),74(88%) 
  
17±3 
  
0(0%), 84(100%) 
<0.0001 
  
<0.0001 
  
0.003 
  
0.0890 
  
0.36 
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Table 6 shows logistic regression analysis for respiratory events in PACU 
 
  Unadjusted odds 
ratio (95% 
confidence 
interval) 
P-value Adjusted odds ratio 
(95% confidence 
interval) 
P-value 
  
  
Study arm 
Operative procedure 
Anesthetic duration 
Duration since last muscle relaxant 
BMI 
  
  
  
  
  
Study arm 
Operative procedure 
Anesthetic duration 
Duration since last muscle relaxant 
BMI 
  
  
  
Study arm 
Operative procedure 
Anesthetic duration 
Duration since last muscle relaxant 
BMI 
  
  
  
Study arm 
Operative procedure 
Anesthetic duration 
Duration since last muscle relaxant 
BMI 
  
Mild hypoxia (90-
93%) 
0.09(0.01- 0.71) 
1.90(1.25 -2.86) 
1.00(1.01-1.01) 
1.01(0.97-1.05) 
  
1.29(0.68-2.43) 
  
  
Tactile stimulation 
  
0.09(0.02-0.40) 
1.16(0.92-1.47) 
1.00(0.997-1.01) 
1.00(0.97-1.03) 
  
1.54(0.92-2.55) 
  
  
Airway maneuver 
0.20(0.10-0.43) 
1.15(0.97-1.36) 
1.00(0.997-1.01) 
1.00(0.97-1.01) 
  
1.33(0.94-1.86) 
  
Snoring 
0.30(0.13-0.68) 
1.03(0.86-1.25) 
1.00(1.00-1.01) 
1.00(0.98-1.02) 
  
1.36(0.92-1.99) 
  
0.023 
0.002 
0.281 
0.548 
  
0.441 
  
  
  
  
0.002 
0.205 
0.305 
0.797 
  
0.098 
  
  
  
<0.001 
0.107 
0.403 
0.420 
  
0.104 
  
  
0.004 
0.717 
0.466 
0.918 
  
0.119 
  
  
0.11(0.14-0.93) 
1.80(1.18-2.74) 
  
  
  
  
  
0.043 
0.006 
-Smoking was not analyzed due to the very small numbers per group (4 each). Adjusted odds ratios were not 
calculated for tactile stimulation, airway manoeuvre and snoring because the other variables were not statistically 
significant. 
  
Operative procedure was associated with almost twice 
risk of  developing mild hypoxia in PACU (unadjusted 
OR 1.90 95% CI 1.25-2.86 P-value 0.002); adjusted OR 
1.80 95% CI 1.18-2.74 P-value 0.006). This is in agree-
ment with a study by Pedersen et al who demonstrated 
increased pulmonary complications after major ortho-
paedic surgery12.
The incidence of  upper airway obstruction requiring an 
airway maneuver was 45% in the clinical assessment group 
and 14% in the TOF group (P-value <0.0001). 21% of  
patients in the clinical assessment group compared to 2% 
in the TOF group required tactile stimulation to main-
tain their airway (P-value <0.0001). More patients in the 
clinical assessment group snored compared to those in 
TOF group (31% versus 12%, P-value 0.003). Logistic re-
gression analysis revealed patients in the TOF group were 
less  likely to require tactile stimulation (unadjusted OR 
0.09 95% CI 0.02-0.40 P-value 0.02), less likely to require 
an airway maneuver (unadjusted OR 0.20 95% CI 0.10-
0.43 P-value <0.001) and less likely to snore (unadjusted 
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OR 0.30 95% CI 0.13-0.68 P-value 0.004) while in PACU. 
No multivariate analysis was done because the other pos-
sible confounders were not statistically significant after 
univariate analysis.
With all the possible confounders adjusted for, it is clear 
that the main determinant of  hypoxia and upper airway 
obstruction in PACU is residual muscle paresis as demon-
strated by less incidence of  hypoxia and upper airway ob-
struction in the TOF group. Neuromuscular monitoring 
using TOF ratio appears to reduce incidence of  critical 
respiratory events in PACU.
Strengths of  the study
Perusal of  the literature appears to indicate that this is 
one of  the few prospective randomized controlled study 
that have compared the impact train of  > 0.9 to clinical 
assessment prior to endotracheal extubation on critically 
respiratory events.this study will add to the body of  liter-
ature and knowledge on prevention of  respiratory events 
in PACU after use of  muscle relaxants.
Limitations of  the study 
This study was conducted at a single centre involving a 
relatively snmall number of  patientshence impacting on 
the generalizability of  our results. This study used TOF 
stimulation that was uncalibrated.This did have a risk of  
showing a TOF count instead of  a TOF ratio .This re-
duces its reliability to guide decisions on pharmacological 
antagonism of  non-depolarising block or to exclude post-
operative residual curarization13. This study also lacked an 
objective measure of  recovery from general anaesthesia 
such as a bispectral monitor. This was because at  our 
hospital, objective measurement of  depth of  anaesthesia 
is not routinely done and this study aimed to mimick nor-
mal clinical practice which is a reflection of  anaesthesia 
practice in Kenya and the whole of  Eastern and Central 
Africa. Lastly, the operative procedures were varied and 
we recommend the study to be done in patients undergo-
ing same surgical procedure.
 
Conclusion
On the basis of  the results of  this study and in this pa-
tient population, the use of  TOF ≥0.9 before tracheal ex-
tubation is associated with decreased critical respiratory 
events in PACU compared to clinical assessment and this 
should be the standard of  care in our operating theatres.
Trial registration: PACTR201501001021110.
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